009420.KS
009420.KS
KR7009420001
HANALL BIOPHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 155.184.524.100 138.943.698.750
11.7%
Cost of Revenue 74.326.624.030 65.637.316.770
13.2%
Gross Profit 80.857.900.070 73.306.381.980
10.3%
81.773.715.000 73.075.907.000
11.9%
Operating Income -915.814.930 230.474.980
497.4%
Pretax Income -6.179.882.940 -183.196.940
3273.4%
Net Income Common Stockholders -5.559.162.630 -1.804.843.470
208.0%
-- --
--
-- --
--
ende